SHH · 605199.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Hainan Huluwa Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.95% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hainan Huluwa Pharmaceutical Group Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥27.45-CN¥0.46 (-1.65%)
Zhejiang Wecome Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.75% below the high.
CN¥5.73-CN¥0.10 (-1.72%)
Guangdong Hybribio Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.1% below the high.
CN¥46.24-CN¥1.94 (-4.03%)
Shanghai Model Organisms Center, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.98% below the high.
CN¥16.09-CN¥0.64 (-3.83%)
Shanghai ZJ Bio-Tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥11.48-CN¥0.26 (-2.21%)
Qingdao Vland Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.64% below the high.
CN¥7.54-CN¥0.19 (-2.46%)
Baolingbao Biology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.5% below the high.
CN¥18.05-CN¥0.52 (-2.8%)
Lifecome Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.95% below the high.
CN¥13.58-CN¥0.04 (-0.29%)
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.88% below the high.
